Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
Lukas Wettstein, Frank Kirchhoff, Jan Münch
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1351-1351
Open Access | Times Cited: 56

Showing 26-50 of 56 citing articles:

Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2
Jiewen Fu, Shuguang Liu, Qi Tan, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7413-7413
Open Access | Times Cited: 8
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012653-e1012653
Open Access | Times Cited: 1
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
Yuanyuan Qiao, Jesse W. Wotring, Yang Zheng, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 30
Open Access | Times Cited: 4
Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19
Matteo Micucci, Silvia Gioacchini, Melissa Baggieri, et al.
Future Foods (2024) Vol. 9, pp. 100303-100303
Open Access | Times Cited: 1
The fatal contribution of serine protease-related genetic variants to COVID-19 outcomes
Laura E. Martínez-Gómez, Carlos Martínez-Armenta, Teresa Tusié‐Luna, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Up, up, down, down: the structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system
Sabrina Stäb, Nicholas M. Pearce, Dale E. Tronrud, et al.
Crystallography Reviews (2024), pp. 1-44
Open Access | Times Cited: 1
SARS-CoV-2 Infection in Microglia and Its Sequelae: What Do We Know So Far?
Echo Yongqi Luo, Raymond Chuen‐Chung Chang, Javier Gilbert‐Jaramillo
Brain Behavior & Immunity - Health (2024) Vol. 42, pp. 100888-100888
Open Access | Times Cited: 1
TMPRSS2 in microbial interactions: Insights from HKU1 and TcsH
Zhengyang Pan, Daoqun Li, Leiliang Zhang
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012677-e1012677
Open Access | Times Cited: 1
The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19—A Prospective Pilot Study
Reut Kassif Lerner, Michal Stein Yeshurun, Rina Hemi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 622-622
Open Access | Times Cited: 7
Will Peptides Help to Stop COVID-19?
Viktoriya G. Krut’, Sergei Chuvpilo, Irina V. Astrakhantseva, et al.
Biochemistry (Moscow) (2022) Vol. 87, Iss. 7, pp. 590-604
Open Access | Times Cited: 6
Preeclampsia to COVID-19: A journey towards improved placental and vascular function using sulforaphane
Neville J. Fields, Kirsten R. Palmer, Anthony Nisi, et al.
Placenta (2023) Vol. 141, pp. 84-93
Open Access | Times Cited: 3
Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview
Anna Gorący, Jakub Rosik, Bartosz Szostak, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1092-1092
Open Access | Times Cited: 5
TMPRSS2 Impacts Cytokine Expression in Murine Dendritic Cells
Sandra Gunne, Marie Schwerdtner, Marina Henke, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 419-419
Open Access | Times Cited: 2
Pulmonary embolism in adolescent with COVID‐19 during aromatase inhibitor therapy
Loukia Ioannidou, Athina Dettoraki, Maria Noni, et al.
Pediatric Pulmonology (2022) Vol. 57, Iss. 7, pp. 1789-1791
Open Access | Times Cited: 3
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2
Andrey A. Ivashchenko, Bogdan Zagribelnyy, Yan A. Ivanenkov, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4975-4975
Open Access | Times Cited: 3
Biochemical characterization, stability, and kinetics of three substrates of the recombinant TMPRSS2 serine protease domain
Flávio Antônio de Oliveira-Simões, Isabela Victorino da Silva Amatto, Camila Langer Marciano, et al.
Preparative Biochemistry & Biotechnology (2024) Vol. 54, Iss. 10, pp. 1285-1293
Closed Access
In silico evidence that substitution of glycine for valine (p.G8V) in a common variant of TMPRSS2 isoform 1 increases accessibility to an endocytic signal: Implication for SARS-cov-2 entry into host cells and susceptibility to COVID-19
Matteo Calcagnile, Fabrizio Damiano, Giambattista Lobreglio, et al.
Biochimie (2024) Vol. 225, pp. 89-98
Closed Access
Feline coronavirus influences the biogenesis and composition of extracellular vesicles derived from CRFK cells
Sandani V. T. Wijerathne, Rachana Pandit, Ayodeji O. Ipinmoroti, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access
Using a static magnetic field to attenuate the severity in COVID-19-invaded lungs
Hsuan-Yu Lai, Kuo-Cheng Fan, Yen-Hua Lee, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Ultrapure and potent tannic acid as a pluripotent protease and influenza HA inhibitor against influenza virus infection
Tsai-Miao Shih, Han-Yi Hsieh, Jhe-Wei Hu, et al.
Future Virology (2024), pp. 1-16
Closed Access
The Proteolytic Activity of Neutrophil-Derived Serine Proteases Bound to the Cell Surface Arming Lung Epithelial Cells for Viral Defense
Akmaral Assylbekova, Maiya Allayarova, Moldir Konysbekova, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4449-4449
Open Access
Cellular and Humoral Immunity and Infection Responses to SARS-CoV-2:Immune Biomolecular Mechanisms by Case Study within SARS-CoV-2 Pathogenesis and Other Infections
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
(2022)
Open Access | Times Cited: 2
Antiviral activity of aminocaproic acid against SARS-CoV-2: review of the literature and results of the first experimental study
Jeanne Chiaravalli, A. Verneuil, V. Osiichuk, et al.
Infusion & Chemotherapy (2022), Iss. 3, pp. 5-12
Open Access | Times Cited: 1
S protein, ACE2 and Host Cell Proteases in SARS-CoV2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword?
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
(2022)
Open Access | Times Cited: 1

Scroll to top